content

ProteoGenix to accelerate the discovery of SARS-CoV-2 antibodies with first human immune COVID-19 library

ProteoGenix, a global leader in antibody production, is pleased to announce the first Human Immune COVID-19 library for the fast discovery of potent antibodies...

Elsevier adds to its extensive free resources for biomedical and scientific researchers working on coronavirus with access to broad suite of tools

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools...

MedPharm Develops Model to Support Coronavirus Pharmaceutical Development

MedPharm, a leading clinical development organization in topical and transdermal drug delivery, has expanded its innovative testing models to support pharmaceutical development programs targeting...

Genalyte Announces Availability of its High-Speed COVID-19 Antibody Test

Genalyte, the company empowering physicians and patients with real-time diagnostics and healthcare analytics, announced the availability of its rapid COVID-19 serology panel on its...

ARTES Biotech to Develop VLP SARS-CoV-2 Vax Candidates

ARTES Biotechnology, a biotech company specializing in process development for recombinant vaccines, entered development of SARS-CoV-2 vaccine candidates based on its virus-like particle (VLP)...

CTI BioPharma Initiates Phase III Pacritinib Trial in COVID-19

CTI BioPharma Corp. initiated PRE-VENT, a Phase III study evaluating pacritinib in hospitalized patients with severe COVID-19. PRE-VENT, a randomized, double-blind, placebo-controlled study, will...

Valo Tx Working to Develop Potential COVID-19 Vaccine

Valo Therapeutics Ltd. (Valo Tx), is working to develop a potential novel COVID-19 vaccine with applications across future pandemics. Valo Tx will use its...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read